MCMANUS MICHAEL A JR

SEC source: 0001104659-26-006263 · tm263951-3_4seq1.xml · derivative · entry 2

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,259 shares

Expires not disclosed

F2 · security: Represents shares of Common Stock underlying a time-based vesting stock option award granted on January 15, 2026 under the Issuer's Amended & Restated 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 4,087 shares of the 12,259 total number of shares on January 15, 2027, and an additional one-third of the total number of shares will vest on January 18, 2028 and January 16, 2029, subject to the Reporting Person's continued service through any vesting date.

F2 · shares: Represents shares of Common Stock underlying a time-based vesting stock option award granted on January 15, 2026 under the Issuer's Amended & Restated 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 4,087 shares of the 12,259 total number of shares on January 15, 2027, and an additional one-third of the total number of shares will vest on January 18, 2028 and January 16, 2029, subject to the Reporting Person's continued service through any vesting date.

F2 · price: Represents shares of Common Stock underlying a time-based vesting stock option award granted on January 15, 2026 under the Issuer's Amended & Restated 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 4,087 shares of the 12,259 total number of shares on January 15, 2027, and an additional one-third of the total number of shares will vest on January 18, 2028 and January 16, 2029, subject to the Reporting Person's continued service through any vesting date.

F2 · derivative.exercise_date: Represents shares of Common Stock underlying a time-based vesting stock option award granted on January 15, 2026 under the Issuer's Amended & Restated 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 4,087 shares of the 12,259 total number of shares on January 15, 2027, and an additional one-third of the total number of shares will vest on January 18, 2028 and January 16, 2029, subject to the Reporting Person's continued service through any vesting date.

F2 · derivative.expiration_date: Represents shares of Common Stock underlying a time-based vesting stock option award granted on January 15, 2026 under the Issuer's Amended & Restated 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 4,087 shares of the 12,259 total number of shares on January 15, 2027, and an additional one-third of the total number of shares will vest on January 18, 2028 and January 16, 2029, subject to the Reporting Person's continued service through any vesting date.

F2 · balance_after: Represents shares of Common Stock underlying a time-based vesting stock option award granted on January 15, 2026 under the Issuer's Amended & Restated 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 4,087 shares of the 12,259 total number of shares on January 15, 2027, and an additional one-third of the total number of shares will vest on January 18, 2028 and January 16, 2029, subject to the Reporting Person's continued service through any vesting date.

SEC source: 0001104659-26-006263 · tm263951-3_4seq1.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 538,600

F1 · security: Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on January 15, 2026, under the Issuer's Amended & Restated 2023 Equity Incentive Plan. One-third, or 6,635 shares of the 19,903 total number of shares of the RSU award will vest on January 15, 2026, and an additional one-third of the total number of shares will vest on January 15, 2027 and January 18, 2028, subject to the Reporting Person's continued service through each vesting date.

F1 · date: Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on January 15, 2026, under the Issuer's Amended & Restated 2023 Equity Incentive Plan. One-third, or 6,635 shares of the 19,903 total number of shares of the RSU award will vest on January 15, 2026, and an additional one-third of the total number of shares will vest on January 15, 2027 and January 18, 2028, subject to the Reporting Person's continued service through each vesting date.

SEC source: 0001654954-25-011433 · section16.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 531,965

SEC source: 0001654954-25-006729 · section16.xml · derivative · entry 2

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 34,100 shares

Expires not disclosed

F2 · security: Represents shares of Common Stock underlying a time-based vesting stock option award granted on May 27, 2025 under the Issuer's 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 11,367 shares of the 34,100 total number of shares on May 27, 2026 and an additional one-third of the total number of shares will vest on May 27, 2027 and May 27, 2028, subject to the Reporting Person's continued service through any vesting date.

F2 · shares: Represents shares of Common Stock underlying a time-based vesting stock option award granted on May 27, 2025 under the Issuer's 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 11,367 shares of the 34,100 total number of shares on May 27, 2026 and an additional one-third of the total number of shares will vest on May 27, 2027 and May 27, 2028, subject to the Reporting Person's continued service through any vesting date.

F2 · price: Represents shares of Common Stock underlying a time-based vesting stock option award granted on May 27, 2025 under the Issuer's 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 11,367 shares of the 34,100 total number of shares on May 27, 2026 and an additional one-third of the total number of shares will vest on May 27, 2027 and May 27, 2028, subject to the Reporting Person's continued service through any vesting date.

F2 · derivative.exercise_date: Represents shares of Common Stock underlying a time-based vesting stock option award granted on May 27, 2025 under the Issuer's 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 11,367 shares of the 34,100 total number of shares on May 27, 2026 and an additional one-third of the total number of shares will vest on May 27, 2027 and May 27, 2028, subject to the Reporting Person's continued service through any vesting date.

F2 · derivative.expiration_date: Represents shares of Common Stock underlying a time-based vesting stock option award granted on May 27, 2025 under the Issuer's 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 11,367 shares of the 34,100 total number of shares on May 27, 2026 and an additional one-third of the total number of shares will vest on May 27, 2027 and May 27, 2028, subject to the Reporting Person's continued service through any vesting date.

F2 · balance_after: Represents shares of Common Stock underlying a time-based vesting stock option award granted on May 27, 2025 under the Issuer's 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 11,367 shares of the 34,100 total number of shares on May 27, 2026 and an additional one-third of the total number of shares will vest on May 27, 2027 and May 27, 2028, subject to the Reporting Person's continued service through any vesting date.

SEC source: 0001654954-25-006729 · section16.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 581,965

F1 · date: Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on May 27,2025 under the Issuer's 2023 Equity Incentive Plan. One-third, or 22,733 shares of the 68,200 total number of shares, of the RSU award vested on May 27, 2025 and an additional one-third of the total number of shares will vest on May 27, 2026 and May 27, 2027, subject to the Reporting Person's continued service through each vesting date.

F1 · shares: Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on May 27,2025 under the Issuer's 2023 Equity Incentive Plan. One-third, or 22,733 shares of the 68,200 total number of shares, of the RSU award vested on May 27, 2025 and an additional one-third of the total number of shares will vest on May 27, 2026 and May 27, 2027, subject to the Reporting Person's continued service through each vesting date.

F1 · price: Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on May 27,2025 under the Issuer's 2023 Equity Incentive Plan. One-third, or 22,733 shares of the 68,200 total number of shares, of the RSU award vested on May 27, 2025 and an additional one-third of the total number of shares will vest on May 27, 2026 and May 27, 2027, subject to the Reporting Person's continued service through each vesting date.

SEC source: 0001654954-24-015390 · section16.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 338,333

SEC source: 0001654954-24-014652 · section16.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 268,333

SEC source: 0001654954-24-010745 · section16.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 218,333

SEC source: 0001654954-24-006958 · section16.xml · derivative · entry 2

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires not disclosed

F2 · security: Represents shares of Common Stock underlying a stock option award granted on March 1, 2024 under the Issuer's 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 166,667 shares of the 500,000 total number of shares on March 1, 2025 and an additional one-third of the total number of shares on each annual anniversary thereafter, subject to the Reporting Person's continued service through any vesting date.

F2 · shares: Represents shares of Common Stock underlying a stock option award granted on March 1, 2024 under the Issuer's 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 166,667 shares of the 500,000 total number of shares on March 1, 2025 and an additional one-third of the total number of shares on each annual anniversary thereafter, subject to the Reporting Person's continued service through any vesting date.

F2 · price: Represents shares of Common Stock underlying a stock option award granted on March 1, 2024 under the Issuer's 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 166,667 shares of the 500,000 total number of shares on March 1, 2025 and an additional one-third of the total number of shares on each annual anniversary thereafter, subject to the Reporting Person's continued service through any vesting date.

F2 · derivative.exercise_date: Represents shares of Common Stock underlying a stock option award granted on March 1, 2024 under the Issuer's 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 166,667 shares of the 500,000 total number of shares on March 1, 2025 and an additional one-third of the total number of shares on each annual anniversary thereafter, subject to the Reporting Person's continued service through any vesting date.

F2 · derivative.expiration_date: Represents shares of Common Stock underlying a stock option award granted on March 1, 2024 under the Issuer's 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 166,667 shares of the 500,000 total number of shares on March 1, 2025 and an additional one-third of the total number of shares on each annual anniversary thereafter, subject to the Reporting Person's continued service through any vesting date.

F2 · balance_after: Represents shares of Common Stock underlying a stock option award granted on March 1, 2024 under the Issuer's 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 166,667 shares of the 500,000 total number of shares on March 1, 2025 and an additional one-third of the total number of shares on each annual anniversary thereafter, subject to the Reporting Person's continued service through any vesting date.

SEC source: 0001654954-24-006958 · section16.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,333

F1 · security: Represents shares of Common Stock underlying a restricted stock unit ("RSU") award granted on March 1, 2024 under the Issuer's 2023 Equity Incentive Plan. One-third, or 83,333 shares of the 250,000 total number of shares, of the RSU award vested on March 1, 2024 and an additional one-third of the total number of shares on each annual anniversary thereafter, subject to the Reporting Person's continued service through each vesting date.

F1 · date: Represents shares of Common Stock underlying a restricted stock unit ("RSU") award granted on March 1, 2024 under the Issuer's 2023 Equity Incentive Plan. One-third, or 83,333 shares of the 250,000 total number of shares, of the RSU award vested on March 1, 2024 and an additional one-third of the total number of shares on each annual anniversary thereafter, subject to the Reporting Person's continued service through each vesting date.

F1 · shares: Represents shares of Common Stock underlying a restricted stock unit ("RSU") award granted on March 1, 2024 under the Issuer's 2023 Equity Incentive Plan. One-third, or 83,333 shares of the 250,000 total number of shares, of the RSU award vested on March 1, 2024 and an additional one-third of the total number of shares on each annual anniversary thereafter, subject to the Reporting Person's continued service through each vesting date.

F1 · price: Represents shares of Common Stock underlying a restricted stock unit ("RSU") award granted on March 1, 2024 under the Issuer's 2023 Equity Incentive Plan. One-third, or 83,333 shares of the 250,000 total number of shares, of the RSU award vested on March 1, 2024 and an additional one-third of the total number of shares on each annual anniversary thereafter, subject to the Reporting Person's continued service through each vesting date.

SEC source: 0001209191-22-038595 · doc4.xml · derivative · entry 2

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 700 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

F2 · derivative.exercise_date: In connection with the reporting person's departure from the Board of Directors (the "Board"), the Board accelerated the vesting of 700 RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), to June 16, 2022 from June 17, 2022.

F2 · derivative.expiration_date: In connection with the reporting person's departure from the Board of Directors (the "Board"), the Board accelerated the vesting of 700 RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), to June 16, 2022 from June 17, 2022.

SEC source: 0001209191-22-038595 · doc4.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,101

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

SEC source: 0001654954-21-013345 · section16.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,452

F1 · security: 763 shares acquired under The Eastern Company Director's Fee Program pursuant to Rule 16b-3(d). The price used to determine the number of shares is the price of the shares on December 15, 2021.

SEC source: 0001654954-21-010226 · section16.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,689

F1 · security: 796 shares acquired under The Eastern Company Director's Fee Program pursuant to Rule 16b-3(d). The price used to determine the number of shares is the price of the shares on September 15, 2021.

SEC source: 0001209191-21-043703 · doc4.xml · derivative · entry 2

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,900 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

F2 · derivative.exercise_date: One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 25, 2020 grant date subject to continued service on the Company's Board of Directors through the vesting date.

F2 · derivative.expiration_date: One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 25, 2020 grant date subject to continued service on the Company's Board of Directors through the vesting date.

SEC source: 0001209191-21-043703 · doc4.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,851

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

SEC source: 0001209191-21-052811 · doc4a.xml · derivative · entry 2

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,450

Underlying: Common Stock · 3,450 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

F1 · shares: This amendment to the original Form 4 filed on June 29, 2021 is being filed to correct the number of restricted stock units ("RSUs") vested on June 25, 2021.

F3 · derivative.exercise_date: One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 25, 2020 grant date subject to continued service on the Company's Board of Directors through the vesting date.

F3 · derivative.expiration_date: One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 25, 2020 grant date subject to continued service on the Company's Board of Directors through the vesting date.

F1 · derivative.underlying_shares: This amendment to the original Form 4 filed on June 29, 2021 is being filed to correct the number of restricted stock units ("RSUs") vested on June 25, 2021.

F1 · balance_after: This amendment to the original Form 4 filed on June 29, 2021 is being filed to correct the number of restricted stock units ("RSUs") vested on June 25, 2021.

SEC source: 0001209191-21-052811 · doc4a.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,401

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This amendment to the original Form 4 filed on June 29, 2021 is being filed to correct the number of restricted stock units ("RSUs") vested on June 25, 2021.

F2 · price: Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

F1 · balance_after: This amendment to the original Form 4 filed on June 29, 2021 is being filed to correct the number of restricted stock units ("RSUs") vested on June 25, 2021.

SEC source: 0001654954-21-007031 · section16.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,893

F1 · security: 580 shares acquired under The Eastern Company Director's Fee Program pursuant to Rule 16b-3(d). The price used to determine the number of shares is the price of the shares on June 15, 2021.

SEC source: 0001209191-21-042457 · doc4.xml · derivative · entry 2

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 700

Underlying: Common Stock · 700 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.

F3 · derivative.exercise_date: One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date.

F3 · derivative.expiration_date: One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date.

SEC source: 0001209191-21-042457 · doc4.xml · derivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,300

Underlying: Common Stock · 1,300 shares

Expires 2031-06-17

F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan") will vest one (1) year from the June 17, 2021 grant date (the "Grant Date") subject to continued service on the Company's Board of Directors through the vesting date.

SEC source: 0001654954-21-003489 · section16.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,313

F1 · security: 732 shares acquired under The Eastern Company Director's Fee Program pursuant to Rule 16b-3(d). The price used to determine the number of shares is the price of the shares on March 15, 2021.

SEC source: 0001209191-21-022613 · doc4.xml · nonDerivative · entry 2

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,951

SEC source: 0001209191-21-022613 · doc4.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,951

SEC source: 0001654954-20-013734 · section16.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,581

F1 · security: 615 shares acquired under The Eastern Company Director's Fee Program pursuant to Rule 16b-3(d). The price used to determine the number of shares is the price of the shares on December 15, 2020.

SEC source: 0001654954-20-010639 · section16.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,966

F1 · security: 890 shares acquired under The Eastern Company Director's Fee Program pursuant to Rule 16b-3(d). The price used to determine the number of shares is the price of the shares on September 15, 2020.

SEC source: 0000904454-20-000590 · edgar.xml · derivative · entry 5

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,000 shares

Expires 2027-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000904454-20-000590 · edgar.xml · derivative · entry 4

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,000 shares

Expires 2027-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000904454-20-000590 · edgar.xml · nonDerivative · entry 3

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,951

SEC source: 0000904454-20-000590 · edgar.xml · nonDerivative · entry 2

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,951

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000904454-20-000590 · edgar.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,951

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-039196 · doc4.xml · derivative · entry 2

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,450

Underlying: Common Stock · 3,450 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.

F3 · derivative.exercise_date: One hundred percent (100%) of the RSUs subject to this grant under the Plan, will vest one (1) year from the Grant Date, subject to continued service on the Company's Board of Directors through the vesting date.

F3 · derivative.expiration_date: One hundred percent (100%) of the RSUs subject to this grant under the Plan, will vest one (1) year from the Grant Date, subject to continued service on the Company's Board of Directors through the vesting date.

SEC source: 0001209191-20-039196 · doc4.xml · derivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,900

Underlying: Common Stock · 6,900 shares

Expires 2030-06-25

F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), will vest one (1) year from the June 25, 2020 grant date (the "Grant Date"), subject to continued service on the Company's Board of Directors through the vesting date.

SEC source: 0001567619-20-012355 · doc1.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,076

F1 · security: 1,059 shares acquired under The Eastern Company Director's Fee Program pursuant to Rule 16b-3(d). The price used to determine the number of shares is the price of the shares on June 15, 2020.

SEC source: 0001567619-20-007168 · doc1.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,017

F1 · security: 778 shares acquired under The Eastern Company Director's Fee Program pursuant to Rule 16b-3(d). The price used to determine the number of shares is the price of the shares on March 13, 2020.

SEC source: 0001567619-19-023543 · doc1.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,239

F1 · security: 390 shares acquired under The Eastern Company Director's Fee Program pursuant to Rule 16b-3(d). The price used to determine the number of shares is the price of the shares on December 13, 2019.

SEC source: 0001209191-19-060694 · doc4.xml · derivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2029-12-12

F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended, will vest one (1) year from the December 12, 2019 grant date subject to continued service on the Company's Board of Directors through the vesting date.

SEC source: 0001209191-19-057437 · doc4.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,951

SEC source: 0001567619-19-018769 · doc1.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,849

F1 · security: 415 shares acquired under The Eastern Company Director's Fee Program pursuant to Rule 16b-3(d). The price used to determine the number of shares is the price of the shares on September 13, 2019.

SEC source: 0001567619-19-013951 · doc1.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,434

F1 · security: 404 shares acquired under The Eastern Company Director's Fee Program pursuant to Rule 16b-3(d). The price used to determine the number of shares is the price of the shares on June 14, 2019.

SEC source: 0001567619-19-007483 · doc1.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,030

F1 · security: 365 shares acquired under The Eastern Company Director's Fee Program pursuant to Rule 16b-3(d). The price used to determine the number of shares is the price of the shares on March 15, 2019.

SEC source: 0001567619-18-008576 · doc1.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,665

F1 · security: 425 shares acquired under The Eastern Company Director's Fee Program pursuant to Rule 16b-3(d). The price used to determine the number of shares is the price of the shares on December 14, 2018.

SEC source: 0001209191-18-062756 · doc4.xml · derivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 90,000 shares

Expires 2028-12-13

F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended, will vest one (1) year from the December 13, 2018 grant date subject to continued service on the Company's Board of Directors through the vesting date.

SEC source: 0001567619-18-003263 · doc1.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,240

F1 · security: 347 shares acquired under The Eastern Company Director's Fee Program pursuant to Rule 16b-3(d). The price used to determine the number of shares is the price of the shares on September 14, 2018.

SEC source: 0001140361-18-029496 · doc1.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,893

F1 · security: 355 shares acquired under The Eastern Company Director's Fee Program pursuant to Rule 16b-3(d). The price used to determine the number of shares is the price of the shares on June 15, 2018.

SEC source: 0001140361-18-014613 · doc1.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,538

F1 · security: 322 shares acquired under The Eastern Company Director's Fee Program pursuant to Rule 16b-3(d). The price used to determine the number of shares is the price of the shares on March 15, 2018.

SEC source: 0001140361-17-047096 · doc1.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,216

F1 · security: 335 shares acquired under The Eastern Company Director's Fee Program pursuant to Rule 16b-3(d). The price used to determine the number of shares is the price of the shares on December 15, 2017.

SEC source: 0001209191-17-066318 · doc4.xml · derivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2027-12-15

F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended, will vest one (1) year from the December 15, 2017 grant date subject to continued service on the Company's Board of Directors through the vesting date.

SEC source: 0001140361-17-036206 · doc1.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,881

F1 · security: 352 shares acquired under The Eastern Company Director's Fee Program pursuant to Rule 16b-3(d). The price used to determine the number of shares is the price of the shares on September 15, 2017.

SEC source: 0001140361-17-025945 · doc1.xml · nonDerivative · entry 1

MCMANUS MICHAEL A JR · CIK 0001051997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,529

F1 · security: 247 shares acquired under The Eastern Company Director's Fee Program pursuant to Rule 16b-3(d). The price used to determine the number of shares is the price of the shares on June 15, 2017.